Clinical and imaging data at 5 days as a surrogate for 90-day outcome in ischemic stroke

Stroke

Volumn 40, Issue 4, 2009, Pages 1332-1333

  Johnston, Karen C ^a,b,d   Barrett, Kevin M ^a   Ding, Yong Hong ^c   Wagner, Douglas P ^b  

^a UNIVERSITY OF VIRGINIA   (United States)

^b UNIVERSITY OF VIRGINIA   (United States)

^c MAYO CLINIC   (United States)

^d UNIVERSITY OF VIRGINIA HEALTH SYSTEM   (United States)

Author keywords

Cerebral ischemia; Models; Prognosis; Statistical; Stroke outcome; Surrogate

Indexed keywords

ADULT; AGED; AREA UNDER THE CURVE; ARTICLE; CEREBROVASCULAR ACCIDENT; CONTROLLED STUDY; DIFFUSION WEIGHTED IMAGING; FEMALE; HUMAN; IMAGE ANALYSIS; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PRIORITY JOURNAL; SCORING SYSTEM; STROKE; BRAIN INFARCTION; BRAIN ISCHEMIA; CLINICAL TRIAL; HOSPITALIZATION; MIDDLE AGED; MULTIVARIATE ANALYSIS; PATHOLOGY; PREDICTION AND FORECASTING; PROSPECTIVE STUDY; ROC CURVE; STATISTICAL MODEL;

AGED; BRAIN ISCHEMIA; CEREBRAL INFARCTION; DIFFUSION MAGNETIC RESONANCE IMAGING; FEMALE; HUMANS; LOGISTIC MODELS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; PREDICTIVE VALUE OF TESTS; PROSPECTIVE STUDIES; ROC CURVE; SEVERITY OF ILLNESS INDEX; STROKE;

EID: 65249109207     PISSN: 00392499     EISSN: None     Source Type: Journal    
DOI: 10.1161/STROKEAHA.108.528976     Document Type: Article

References (9)

1. Lees Kennedy R, Hankey Graeme J, Hacke Werner. Design of future acute-stroke treatment trials. Lancet Neurology. 2003;2:54-61.
2. Johnston Karen C, Wagner Douglas P, Haley EC Jr, Connors Alfred F Combined clinical and imaging information as an early stroke outcome measure. Stroke. 2002;33:466-472.
3. Higashida Randall T, Furlan AJ. Trial Design and Reporting Standards for Intra-arterial cerebral thrombolysis for acute ischemic stroke. Stroke. 2003; 34:e109-e137.
4. Brown Devin L, Johnston, Karen C. Wagner Douglas P, Haley EC Jr. Predicting major neurological improvement with intravenous recombinant tissue plasminogen activator treatment of stroke. Stroke. 2004;35:147-150.
5. Johnston KC, Wagner DP, Wang Xin-Qun, Newman George C, Hijs Vincent, Sen Souvik, Warach Steven for the GAIN, Citicoline and ASAP Investigators. Validation of an acute ischemic stroke model. Does diffusion-weighted imaging lesion volume offer a clinically significant improvement in prediction of outcome? Stroke. 2007;38:1820-1825.
6. Baird AE, Benfield A, Schlaug G, Siewert B. Lovblad KO. Edelman RR. Warach S. Enlargement of human cerebral ischemic lesion volumes measured by diffusion-weighted magnetic resonance imaging. Ann Neurol. 1997;41:581-589.
7. Harrell FE. Regression Modeling Strategies. New York: Springer 2001.
8. Saver JL, Johnston KC, Homer D, Wityk R, Koroshetz W, Truskowski LL, Haley EC and the RANTTAS Investigators. Infarct volume as a surrogate or auxiliary outcome measure in ischemic stroke clinical trials. Stroke. 1999;30:293-298.
9. Thijs VN, Adami A, Neumann-Haefelin T, Moseley ME, Marks MP, Albers GW. Relationship between severity of MR perfusion deficit and DWI lesion evolution. Neurology. 2001;57:1205-1211.